Nab-paclitaxel plus carboplatin as an effective and safe chemotherapy regimen for pulmonary carcinosarcoma with interstitial lung disease: A case report

por Niwa, Hideyuki, Otani, Sakiko, Nakada, Norihiro, Sasaki, Jiichiro, Saka, Hideo, Masuda, Noriyuki
Publicado 2018

Successful Chemotherapy with Carboplatin and S-1 for Thymic Carcinoma: A Case Report

por Igawa, Satoshi, Yanagisawa, Nobuyuki, Ishihara, Mikiko, Kimura, Michiko, Maki, Sachiyo, Otani, Sakiko, Sasaki, Jiichiro, Masuda, Noriyuki
Publicado 2013

MET amplification results in heterogeneous responses to osimertinib in EGFR‐mutant lung cancer treated with erlotinib

por Nishiyama, Akihiro, Takeuchi, Shinji, Adachi, Yuta, Otani, Sakiko, Tanimoto, Azusa, Sasaki, Motoko, Matsumoto, Shingo, Goto, Koichi, Yano, Seiji
Publicado 2020

Trametinib overcomes KRAS‐G12V–induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR‐mutant lung cancer

por Fukuda, Koji, Otani, Sakiko, Takeuchi, Shinji, Arai, Sachiko, Nanjo, Shigeki, Tanimoto, Azusa, Nishiyama, Akihiro, Naoki, Katsuhiko, Yano, Seiji
Publicado 2021

Promising Response to Dabrafenib Plus Trametinib in a Patient with Peritoneal Carcinomatosis from Non Small Lung Cancer Harboring BRAF V600E Mutation

por Yagami, Yuri, Nakahara, Yoshiro, Manabe, Hideaki, Yamamoto, Hiroki, Otani, Sakiko, Sato, Takashi, Igawa, Satoshi, Kubota, Masaru, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2022

Successful Chemotherapy with Nab-Paclitaxel in a Heavily Treated Non-Small Cell Lung Cancer Patient: A Case Report

por Ishihara, Mikiko, Igawa, Satoshi, Maki, Sachiyo, Harada, Shinya, Kusuhara, Seiichiro, Niwa, Hideyuki, Otani, Sakiko, Sasaki, Jiichiro, Jiang, Shi-Xu, Masuda, Noriyuki
Publicado 2014

Bronchoesophageal fistula formation after three courses of nivolumab for carcinoma of unknown primary with a subgroup of lung squamous cell carcinoma

por Nishiyama, Akihiro, Sakaguchi, Hiroyuki, Yanagimura, Naohiro, Suzuki, Chiaki, Otani, Sakiko, Tanimoto, Azusa, Yamashita, Kaname, Takeuchi, Shinji, Ohtsubo, Koushiro, Ikeda, Hiroko, Yano, Seiji
Publicado 2020

Questionnaire survey on patient awareness of invasive rebiopsy in advanced non‐small cell lung cancer

por Fukui, Tomoya, Ishihara, Mikiko, Kasajima, Masashi, Hiyoshi, Yasuhiro, Nakahara, Yoshiro, Otani, Sakiko, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2019

Circulating tumor cells as a prognostic factor in patients with small cell lung cancer

por IGAWA, SATOSHI, GOHDA, KEIGO, FUKUI, TOMOYA, RYUGE, SHINICHIRO, OTANI, SAKIKO, MASAGO, AKINORI, SATO, JUN, MURAKAMI, KATSUHIRO, MAKI, SACHIYO, KATONO, KEN, TAKAKURA, AKIRA, SASAKI, JIICHIRO, SATOH, YUKITOSHI, MASUDA, NORIYUKI
Publicado 2014

Long-term disease-free survivor of metastatic large-cell neuroendocrine carcinoma of the lung treated with amrubicin and irinotecan

por Ryuge, Shinichiro, Jiang, Shi-Xu, Wada, Mayuko, Katono, Ken, Iwasaki, Maiko, Takakura, Akira, Otani, Sakiko, Kimura, Yuka, Fukui, Tomoya, Yokoba, Masanori, Kubota, Masaru, Katagiri, Masato, Hayakawa, Kazusige, Masuda, Noriyuki
Publicado 2009

Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer

por Shirasawa, Masayuki, Fukui, Tomoya, Kusuhara, Seiichiro, Hiyoshi, Yasuhiro, Ishihara, Mikiko, Kasajima, Masashi, Nakahara, Yoshiro, Otani, Sakiko, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2018

Patient‐derived xenograft models of non‐small cell lung cancer for evaluating targeted drug sensitivity and resistance

por Kita, Kenji, Fukuda, Koji, Takahashi, Hiro, Tanimoto, Azusa, Nishiyama, Akihiro, Arai, Sachiko, Takeuchi, Shinji, Yamashita, Kaname, Ohtsubo, Koshiro, Otani, Sakiko, Yanagimura, Naohiro, Suzuki, Chiaki, Ikeda, Hiroko, Tamura, Masaya, Matsumoto, Isao, Yano, Seiji
Publicado 2019

Randomized phase II trial of S‐1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non‐small cell lung cancer

por Shimokawa, Tsuneo, Yamada, Kazuhiko, Tanaka, Hiroshi, Kubota, Kaoru, Takiguchi, Yuichi, Kishi, Kazuma, Saito, Haruhiro, Hosomi, Yukio, Kato, Terufumi, Harada, Daijiro, Otani, Sakiko, Kasai, Takashi, Nakamura, Yoichi, Misumi, Toshihiro, Yamanaka, Takeharu, Okamoto, Hiroaki
Publicado 2020

Multicenter, single-arm phase II study of modified carboplatin/nab-paclitaxel in untreated performance status 2 patients with advanced non-small cell lung cancer: TORG1426

por Ichikawa, Yasuko, Seki, Nobuhiko, Honda, Takeshi, Sakugawa, Makoto, Hosokawa, Shinobu, Bessho, Akihiro, Agemi, Yoko, Shimokawa, Tsuneo, Otani, Sakiko, Nakahara, Yoshiro, Naoki, Katsuhiko, Yomota, Makiko, Hosomi, Yukio, Takiguchi, Yuichi, Tokito, Takaaki, Ando, Shuji, Okamoto, Hiroaki
Publicado 2023

Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With EGFR T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyro...

por Akamatsu, Hiroaki, Toi, Yukihiro, Hayashi, Hidetoshi, Fujimoto, Daichi, Tachihara, Motoko, Furuya, Naoki, Otani, Sakiko, Shimizu, Junichi, Katakami, Nobuyuki, Azuma, Koichi, Miura, Naoko, Nishino, Kazumi, Hara, Satoshi, Teraoka, Shunsuke, Morita, Satoshi, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki
Publicado 2021

Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung ca...

por Misumi, Yuki, Okamoto, Hiroaki, Sasaki, Jiichiro, Masuda, Noriyuki, Ishii, Mari, Shimokawa, Tsuneo, Hosomi, Yukio, Okuma, Yusuke, Nagamata, Makoto, Ogura, Takashi, Kato, Terufumi, Sata, Masafumi, Otani, Sakiko, Takakura, Akira, Minato, Koichi, Miura, Yosuke, Yokoyama, Takuma, Takata, Saori, Naoki, Katsuhiko, Watanabe, Koshiro
Publicado 2017

Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer comb...

por Ikeda, Satoshi, Kato, Terufumi, Ogura, Takashi, Sekine, Akimasa, Oda, Tsuneyuki, Masuda, Noriyuki, Igawa, Satoshi, Katono, Ken, Otani, Sakiko, Yamada, Kouzo, Saito, Haruhiro, Kondo, Tetsuro, Hosomi, Yukio, Nakahara, Yoshiro, Nishikawa, Masanori, Utumi, Keiko, Misumi, Yuki, Yamanaka, Takeharu, Sakamaki, Kentaro, Okamoto, Hiroaki
Publicado 2018

Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial

por Wada, Tatsuhiko, Hibino, Makoto, Aono, Hiromi, Kyoda, Shunsuke, Iwadate, Yosuke, Shishido, Eri, Ikeda, Keisuke, Kinoshita, Nana, Matsuda, Yasuki, Otani, Sakiko, Kameda, Ryo, Matoba, Kenta, Nonaka, Miwa, Maeda, Mika, Kumagai, Yuji, Ako, Junya, Shichiri, Masayoshi, Naoki, Katsuhiko, Katagiri, Masato, Takaso, Masashi, Iwamura, Masatsugu, Katayama, Kazuhiko, Miyatsuka, Takeshi, Orihashi, Yasushi, Yamaoka, Kunihiro
Publicado 2023